Breaking News Instant updates and real-time market news.

08:55
03/31/20
03/31
08:55
03/31/20
08:55

U.S. equities have moved lower

U.S. equities have moved lower in pre-market trading following yesterday's 3% rally. Portfolio rebalancing will be a focus again today after providing support for Monday's solid gains on Wall Street. Notably, Bloomberg reports that rebalancing may be put on hold, in some cases, as some of the rotations are delayed due to the exclusion of some bonds due to the huge moves in markets seen during March. The Dow is down -0.7%, the S&P 500 is off -0.9% and the NASDAQ has fallen -0.6% in futures trading. European bourses are weaker, but only mildly so -- the Euro Stoxx has fallen -0.9%, Germany's DAX is off -0.5% and France's CAC 40 is -1.0% in the red. The UK's FTSE 100 is holding around unchanged levels. Asian markets were mixed, as Japan's Nikkei 225 closed with a -0.9% loss, but Hong Kong's Hang Seng rallied 1.9% and China's CSI 300 edged up 0.3%.

TODAY'S FREE FLY STORIES

Hot Stocks
Twitter 'doing nothing' on China propaganda, 'will be regulated,' Trump tweets » 07:18
05/29/20
05/29
07:18
05/29/20
07:18
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

Hot Stocks
Akari Therapeutics expects interim update on Phase I/II trial in AKC in mid-2020 » 07:17
05/29/20
05/29
07:17
05/29/20
07:17
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The Company completed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
Aveo Pharmaceuticals DEDUCTIVE trial advances to Phase 2 portion » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AVEO

Aveo Pharmaceuticals

$9.22 /

+0.47 (+5.37%)

, AZN

AstraZeneca

$53.50 /

+1.04 (+1.98%)

Aveo (AVEO) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
03/31/20 Piper Sandler
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler
03/18/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $4 from $1.75 at H.C. Wainwright
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

Hot Stocks
Akari Therapeutics sees site initiations delayed for Phase III trial in HSCT-TMA » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

During Q1 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Upgrade
Hella KGaA Hueck upgraded to Equal Weight from Underweight at Morgan Stanley » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
HLLGY

Hella KGaA Hueck

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLLGY Hella KGaA Hueck
$0.00 /

+ (+0.00%)

05/27/20 JPMorgan
Hella KGaA Hueck price target raised to EUR 35 from EUR 32 at JPMorgan
05/27/20 Kepler Cheuvreux
Hella KGaA Hueck downgraded to Reduce from Buy at Kepler Cheuvreux
03/26/20 Kepler Cheuvreux
Hella KGaA Hueck upgraded to Buy from Hold at Kepler Cheuvreux
03/25/20 Jefferies
Hella KGaA Hueck upgraded to Buy from Hold at Jefferies
Recommendations
Zscaler price target raised to $100 from $80 at Wedbush » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
06:14 Today Citi
Zscaler price target raised to $86 from $49 at Citi
06:03 Today Piper Sandler
Zscaler price target raised to $75 from $55 at Piper Sandler
05/26/20 Cowen
Zscaler price target raised to $80 from $70 at Cowen
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Hot Stocks
Akari Therapeutics expects to meet with FDA, EMA on nomacopan for BP in Q3 » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

In May 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Upgrade
Polaris upgraded to Outperform at Wedbush as state reopening play » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
PII

Polaris

$89.00 /

-1.885 (-2.07%)

Wedbush analyst James…

Wedbush analyst James Hardiman upgraded Polaris to Outperform from Neutral with a price target of $106, up from $68. The stock closed Thursday down $2.06 to $88.83. The powersports names in general, and Polaris in particular, could prove to be "great" ways to play the reopening of states, Hardiman tells investors in a research note. Consumers have been cooped up in their homes for months will take to the outdoors, while still being conscious of the ongoing risks associated with travel and large crowds, says the analyst. Even though Polaris shares have doubled off their bottom, the 13% year-to-date decline suggests that investors have yet to "fully digest this new bull case," contends Hardiman, who believes such a realization should push the shares past their pre-COVID highs.

ShowHide Related Items >><<
PII Polaris
$89.00 /

-1.885 (-2.07%)

PII Polaris
$89.00 /

-1.885 (-2.07%)

06:32 Today Wedbush
Polaris Industries upgraded to Outperform from Neutral at Wedbush
05/28/20 Raymond James
Polaris Industries price target raised to $108 from $81 at Raymond James
05/18/20 UBS
Polaris Industries price target lowered to $86 from $114 at UBS
04/30/20 KeyBanc
Polaris Industries price target raised to $90 from $70 at KeyBanc
PII Polaris
$89.00 /

-1.885 (-2.07%)

Downgrade
BRP Inc. downgraded to Sector Perform from Outperform at RBC Capital » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
DOOO

BRP Inc.

$35.39 /

-1.66 (-4.48%)

RBC Capital analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOOO BRP Inc.
$35.39 /

-1.66 (-4.48%)

DOOO BRP Inc.
$35.39 /

-1.66 (-4.48%)

05:36 Today RBC Capital
BRP Inc. downgraded to Sector Perform from Outperform at RBC Capital
05/22/20 RBC Capital
BRP Inc. price target raised to C$46 from C$40 at RBC Capital
05/22/20 TD Securities
BRP Inc. price target raised to C$49 from C$30 at TD Securities
05/12/20 National Bank
National Bank downgrades BRP after 118% rebound off lows
Downgrade
VF Corp. downgraded to Hold from Buy at Argus » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
VFC

VF Corp.

$58.84 /

-3.33 (-5.36%)

Argus downgraded VF Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

05/18/20 Susquehanna
VF Corp. price target lowered to $60 from $66 at Susquehanna
05/18/20 Credit Suisse
VF Corp. price target lowered to $60 from $70 at Credit Suisse
04/28/20 BTIG
VF Corp. initiated with a Neutral at BTIG
04/23/20 Guggenheim
VF Corp. price target lowered to $75 from $105 at Guggenheim
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

Hot Stocks
Canopy Growth reports Q4 adjusted EBITDA (C$102M) » 07:14
05/29/20
05/29
07:14
05/29/20
07:14
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

A C$5M wider loss versus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Recommendations
Williams-Sonoma price target raised to $90 from $80 at Wedbush » 07:14
05/29/20
05/29
07:14
05/29/20
07:14
WSM

Williams-Sonoma

$73.18 /

-0.215 (-0.29%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

06:45 Today RBC Capital
Williams-Sonoma price target raised to $76 from $70 at RBC Capital
05/26/20 Telsey Advisory
Williams-Sonoma upgraded to Outperform from Market Perform at Telsey Advisory
05/18/20 Wedbush
Williams-Sonoma upgraded to Outperform at Wedbush
05/18/20 Wedbush
Williams-Sonoma upgraded to Outperform from Neutral at Wedbush
WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

WSM Williams-Sonoma
$73.18 /

-0.215 (-0.29%)

Earnings
Akari Therapeutics reports Q1 EPS (0c) vs. (0c) last year » 07:13
05/29/20
05/29
07:13
05/29/20
07:13
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

"We remain focused…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
Canopy Growth reports Q4 adjusted gross margin 42% » 07:13
05/29/20
05/29
07:13
05/29/20
07:13
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

Reported gross margin,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Hot Stocks
Kite Realty Group launches Re-opening Resources program » 07:12
05/29/20
05/29
07:12
05/29/20
07:12
KRG

Kite Realty Group

$10.32 /

-0.42 (-3.91%)

Kite Realty Group Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRG Kite Realty Group
$10.32 /

-0.42 (-3.91%)

04/16/20 Compass Point
Kite Realty may need to reduce dividend, says Compass Point in downgrade
04/16/20 Compass Point
Kite Realty Group downgraded to Neutral from Buy at Compass Point
03/03/20
Kite raised to Buy, Retail Properties cut to sell in Compass Point REIT shake-up
03/03/20 Compass Point
Kite Realty Group upgraded to Buy from Neutral at Compass Point
KRG Kite Realty Group
$10.32 /

-0.42 (-3.91%)

Downgrade
Hugo Boss downgraded to Hold from Buy at Jefferies » 07:12
05/29/20
05/29
07:12
05/29/20
07:12
BOSSY

Hugo Boss

$0.00 /

+ (+0.00%)

Jefferies analyst Kathryn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOSSY Hugo Boss
$0.00 /

+ (+0.00%)

05:29 Today DZ Bank
Hugo Boss downgraded to Hold from Buy at DZ Bank
05/07/20 HSBC
Hugo Boss price target lowered to EUR 26.50 from EUR 50 at HSBC
05/06/20 Deutsche Bank
Hugo Boss price target lowered to EUR 31 from EUR 35 at Deutsche Bank
05/06/20 JPMorgan
Hugo Boss price target lowered to EUR 41 from EUR 45 at JPMorgan
Hot Stocks
Aveo presents results from final analysis of Phase 3 TIVO-3 trial » 07:11
05/29/20
05/29
07:11
05/29/20
07:11
AVEO

Aveo Pharmaceuticals

$9.22 /

+0.47 (+5.37%)

Aveo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
03/31/20 Piper Sandler
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler
03/18/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $4 from $1.75 at H.C. Wainwright
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

Hot Stocks
Oncolytics: ePoster published from phase 1b study of pelareorep-carfilzomib » 07:10
05/29/20
05/29
07:10
05/29/20
07:10
ONCY

Oncolytics

$2.45 /

+0.14 (+6.06%)

Oncolytics announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCY Oncolytics
$2.45 /

+0.14 (+6.06%)

ONCY Oncolytics
$2.45 /

+0.14 (+6.06%)

05/11/20 RBC Capital
Oncolytics price target lowered to C$6 from C$9 at RBC Capital
01/02/20 Roth Capital
Oncolytics price target raised to $9 from $6.80 at Roth Capital
09/04/19
Fly Intel: Top five analyst initiations
09/04/19 Roth Capital
Oncolytics initiated with a Buy at Roth Capital
Hot Stocks
Myriad Genetics presents new data on riskScore test » 07:10
05/29/20
05/29
07:10
05/29/20
07:10
MYGN

Myriad Genetics

$14.43 /

-0.15 (-1.03%)

Myriad Genetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
02/07/20 JPMorgan
Myriad Genetics price target lowered to $17 from $20 at JPMorgan
MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

MYGN Myriad Genetics
$14.43 /

-0.15 (-1.03%)

Recommendations
Toll Brothers price target raised to $37 from $31 at RBC Capital » 07:09
05/29/20
05/29
07:09
05/29/20
07:09
TOL

Toll Brothers

$32.30 /

-0.65 (-1.97%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

Upgrade
Provident Financial upgraded to Buy from Hold at Jefferies » 07:09
05/29/20
05/29
07:09
05/29/20
07:09
FPLPY

Provident Financial

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPLPY Provident Financial
$0.00 /

+ (+0.00%)

04/20/20 JPMorgan
Provident Financial price target lowered to 200 GBp from 240 GBp at JPMorgan
Hot Stocks
OraSure to acquire UrSure for cash » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
OSUR

OraSure

$13.52 /

-0.1 (-0.73%)

OraSure Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$13.52 /

-0.1 (-0.73%)

OSUR OraSure
$13.52 /

-0.1 (-0.73%)

04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$13.52 /

-0.1 (-0.73%)

Hot Stocks
Apogee Enterprises appoints Nisheet Gupta as CFO » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
APOG

Apogee Enterprises

$21.54 /

-0.53 (-2.40%)

Apogee Enterprises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

04/03/20 DA Davidson
Apogee Enterprises price target lowered to $22 from $35 at DA Davidson
12/20/19 DA Davidson
Apogee Enterprises price target lowered to $35 from $40 at DA Davidson
06/28/19 Craig-Hallum
Apogee Enterprises price target raised to $52 after Q1 report at Craig-Hallum
APOG Apogee Enterprises
$21.54 /

-0.53 (-2.40%)

Recommendations
Lululemon price target raised to $335 from $250 at Raymond James » 07:08
05/29/20
05/29
07:08
05/29/20
07:08
LULU

Lululemon

$284.60 /

+2.91 (+1.03%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

05/21/20
Lululemon reopened over 150 locations, to open another 200 in next 2 weeks
05/19/20 B. Riley FBR
Lululemon price target raised to $290 from $256 at B. Riley FBR
05/18/20 Piper Sandler
Lululemon price target raised to $265 from $249 at Piper Sandler
05/14/20 Cowen
Lululemon price target raised to $280 from $235 at Cowen
LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

LULU Lululemon
$284.60 /

+2.91 (+1.03%)

Hot Stocks
Canopy Growth withdraws previous milestones for positive adj. EBITDA, net income » 07:07
05/29/20
05/29
07:07
05/29/20
07:07
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

Canopy Growth expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.